Serial circulating tumor DNA analysis to assess recurrence risk, benefit of adjuvant therapy, growth rate and early relapse detection in stage III colorectal cancer patients.

被引：6
|
作者：
Henriksen, Tenna V. Vesterman
Tarazona, Noelia
Frydendahl, Amanda
Reinert, Thomas
Carbonell-Asins, Juan Antonio
Sharma, Shruti
Renner, Derrick
Roda, Desamparados
Huerta, Marisol
Rosello, Susana
Gotschalck, Kare Andersson
Iversen, Lene H.
Love, Uffe S.
Thorlacius-Ussing, Ole
Sethi, Himanshu
Aleshin, Alexey
Cervantes, Andres
Andersen, Claus Lindbjerg
机构：
[1] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark
[2] Univ Valencia, Biomed Res Inst INCLIVA, Valencia, Spain
[3] Aarhus Univ Hosp, Dept Mol & Clin Med, Aarhus, Denmark
[4] Univ Valencia, INCLIVA Biomed Res Inst, Dept Med Oncol, Inst Salud Carlos III,CIBERONC, Valencia, Spain
[5] Natera Inc, San Carlos, CA USA
[6] Univ Valencia, INCLIVA Biomed Res Inst, Dept Med Oncol, Valencia, Spain
[7] Reg Hosp Randers, Dept Surg, Randers, Denmark
[8] Aarhus Univ Hosp, Dept Surg, Aarhus, Denmark
[9] Regionshosp Viborg, Dept Surg, Viborg, Denmark
[10] Aalborg Univ Hosp, Dept Gastrointestinal Surg, Aalborg, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.3540
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3540
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating tumor DNA analysis for assessment of recurrence risk, benefit of adjuvant therapy, and early relapse detection after treatment in colorectal cancer patients.
    Henriksen, Tenna, V
    Tarazona, Noelia
    Reinert, Thomas
    Carbonell-Asins, Juan Antonio
    Renner, Derrick
    Sharma, Shruti
    Roda, Desamparados
    Huerta, Marisol
    Rosello, Susana
    Iversen, Lene H.
    Gotschalck, Kare Andersson
    Madsen, Anders Husted
    Andersen, Per Vadgaard
    Thorlacius-Ussing, Ole
    Love, Uffe S.
    Sethi, Himanshu
    Aleshin, Alexey
    Cervantes, Andres
    Andersen, Claus Lindbjerg
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
    Tie, Jeanne
    Cohen, Joshua D.
    Wang, Yuxuan
    Christie, Michael
    Simons, Koen
    Lee, Margaret
    Wong, Rachel
    Kosmider, Suzanne
    Ananda, Sumitra
    McKendrick, Joseph
    Lee, Belinda
    Cho, Jin Hee
    Faragher, Ian
    Jones, Ian T.
    Ptak, Janine
    Schaeffer, Mary J.
    Silliman, Natalie
    Dobbyn, Lisa
    Li, Lu
    Tomasetti, Cristian
    Papadopoulos, Nicholas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    JAMA ONCOLOGY, 2019, 5 (12) : 1710 - 1717
  • [3] Serial circulating tumor DNA analysis for detection of residual disease, assessment of adjuvant therapy efficacy and for early recurrence detection in colorectal cancer
    Reinert, T.
    Henriksen, T. V.
    Rasmussen, M. H.
    Sethi, H.
    Salari, R.
    Shchegrova, S.
    Swenerton, R.
    Wu, H-T.
    Sharma, S.
    Christensen, E.
    Natarajan, P.
    Dashner, S.
    Tin, T.
    Olson, A.
    Pawar, H.
    Zimmermann, B.
    Iversen, L. H.
    Madsen, M. R.
    Lin, J.
    Andersen, C. L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Analysis of circulating tumour DNA for early relapse detection in stage III colorectal cancer after adjuvant chemotherapy
    Jacobs, S. A.
    Sethi, H.
    Kolveska, T.
    George, T. J.
    Shchegrova, S.
    Tin, T.
    Lee, J.
    Olson, A.
    Renner, D.
    Kalashnikova, E.
    Yothers, G.
    Wolmark, N.
    Pogue-Geile, K. L.
    Srinivasan, A.
    Kortmansky, J.
    Louie, M.
    Salari, R.
    Zimmermann, B.
    Aleshin, A.
    Allegra, C. J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Circulating tumor DNA analysis predicting recurrence risk in patients with stage I-III colorectal cancer
    Gu, J.
    Lei, F.
    Wang, X.
    Huang, W.
    He, X.
    Hong, Y.
    Zeng, Q.
    Wang, Y.
    Gao, Q.
    Niu, P.
    Huang, D.
    Gao, Z.
    Ding, C.
    Zhai, Z.
    An, K.
    Chen, H.
    Zhao, X.
    Chen, S.
    Bai, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S561 - S561
  • [6] Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer
    Roufai, Diana Bello
    Bidard, Francois-Clement
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [7] Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer (vol 66, pg 584, 2019)
    Tie, J.
    Cohen, J. D.
    Wang, Y.
    JAMA ONCOLOGY, 2019, 5 (12) : 1811 - 1811
  • [8] Circulating tumor DNA as a marker of recurrence risk in stage III colorectal cancer: The α-CORRECT study
    Schoen, Robert E.
    Diergaarde, Brenda
    Young, Gregory
    Hall, David W.
    Marti, Tara
    Mazloom, Amin
    Costa, Gina
    Subramaniam, Somasundaram
    Palomares, Melanie R.
    Garces, Jorge
    Baehner, Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 302 - 302
  • [9] Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT Study
    Diergaarde, Brenda
    Young, Greg
    Hall, David W.
    Mazloom, Amin
    Costa, Gina L.
    Subramaniam, Soma
    Palomares, Melanie R.
    Garces, Jorge
    Baehner, Frederick L.
    Schoen, Robert E.
    xact Sciences MRD Group
    JOURNAL OF SURGICAL ONCOLOGY, 2025,
  • [10] Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
    Grancher, Adrien
    Beaussire, Ludivine
    Manfredi, Sylvain
    Le Malicot, Karine
    Dutherage, Marie
    Verdier, Vincent
    Mulot, Claire
    Bouche, Olivier
    Phelip, Jean-Marc
    Levache, Charles-Briac
    Deguiral, Philippe
    Coutant, Sophie
    Sefrioui, David
    Emile, Jean-Francois
    Laurent-Puig, Pierre
    Bibeau, Frederic
    Michel, Pierre
    Sarafan-Vasseur, Nasrin
    Lepage, Come
    Di Fiore, Frederic
    FRONTIERS IN ONCOLOGY, 2022, 12
12345